Table 2.
Treatment process measures by condition
| Measure No. (%) | CM (n = 73) | ACC (n = 71) | CM+ACC (n = 82) | UCC (n = 79) | χ2 | p-value |
|---|---|---|---|---|---|---|
| ACC and CM Sessions\a | ||||||
| None | 6 (8) | 6 (9) | 4 (5) | 79 (100) | 239.15 | <.01 |
| 1–3 Sessions | 16 (22) | 16 (23) | 12 (15) | 0 (0) | ||
| 4+ Sessions | 51 (70) | 49 (69) | 66 (81) | 0 (0) | ||
| Usual Continuing Care sessions | ||||||
| None | 36 (50) | 42 (59) | 38 (48) | 29 (37) | 7.52 | 0.28 |
| 1–3 Sessions | 8 (11) | 6 (9) | 8 (10) | 11 (14) | ||
| 4+ Sessions | 28 (39) | 23 (32) | 34 (43) | 38 (49) | ||
| Total CM/ACC/UCC Sessions\b | ||||||
| None | 4 (6) | 6 (9) | 2 (2) | 29 (37) | 53.28 | < .01 |
| 1–3 Sessions | 13 (18) | 12 (17) | 11 (13) | 11 (14) | ||
| 4+ Sessions | 56 (77) | 53 (75) | 69 (84) | 38 (49) | ||
\a
When compared across the three experimental conditions only, there was no significant difference, χ2(1) = 3.31, p = .52.
\b
When compared across the three experimental conditions only, there was no significant difference, χ2 (1) = 3.62, p = .47.